Diabytes
Gambia cough syrup deaths News
)
Drugs Controller General of India (DCGI) Dr V G Somani said a statement issued by WHO in October in the wake of the deaths "was unfortunately amplified by the global media which led to a narrative being built internationally targeting the quality of Indian pharmaceutical products".
)
Rutendo Kuwana from the WHO on October 13 had written to the DCGI seeking to know the progress with the investigation of the manufacturer of the four cough syrups -- the Sonipat-based Maiden Pharmaceuticals.
)
Gambia child death case: The World Health Organisation has issued alerts of India-made Maiden Pharmaceuticals Limited cough syrup "potentially linked with acute kidney injuries and 66 children`s death".
)
External Affairs Minister Dr S. Jaishankar expressed his deepest condolences to his Gambian counterpart
The committee will examine and analyse adverse event reports, causal relationships and all related details shared by WHO
It will suitably advise and recommend to the DCGI about the further course of action
Loading...
 "Will Hindus get justice in Bengal's Murshidabad?")
 "DNA: Uproar over freebies in Delhi!")
 "DNA: AIMIM plans to field 2020 Delhi riots accused Shahrukh Pathan")
 "DNA: A report showing the reality of Bangladesh")
 "DNA: Power Theft Allegations Against SP MP Ziaur Rahman Barq")
 "DNA: Hot Tea Linked to Cancer Risk!")
 "DNA: Why Jordan Fears After Syria’s Coup?")
 "DNA: NSA Ajit Doval’s China Visit - Inside Story")
 "DNA: Gandhi Family Ruined My Career, says Mani Shankar Aiyar")
 "DNA: Ground Report- Tight Security Arrangements for Mahakumbh")
